Papers: 10.1186/s13023-018-0966-4

https://doi.org/10.1186/s13023-018-0966-4

Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA)

Cited by: 9
Author(s): A. Delgado Jiménez, Arantza Ais, Amélie Beaudet, Alicia Gil
Published: over 6 years ago

Software Mentions 1